Legiehn Gerald M, Heran Manraj K S
Division of Interventional Radiology, Department of Radiology, Vancouver General Hospital, University of British Columbia, 899 West 12th Avenue, Vancouver, BC, Canada.
Radiol Clin North Am. 2008 May;46(3):545-97, vi. doi: 10.1016/j.rcl.2008.02.008.
Venous malformations are categorized as low-flow vascular malformations within the domain of vascular anomalies and are the most common vascular malformation encountered clinically. Venous malformations are by definition present at birth, undergo pari passu growth, and present clinically because of symptoms related to mass effect or stasis. Although diagnosis can usually be made by clinical history and examination, differentiation from other vascular and nonvascular entities often requires an imaging work-up that includes ultrasound, CT, MR imaging, and diagnostic phlebography. All decisions regarding imaging work-up and decision to treat must be coordinated though referral and discussions with a multidisciplinary team and be based on clearly defined clinical indications. Percutaneous image-guided sclerotherapy has become the mainstay of treatment for venous malformations and involves the introduction of any one of a number of endothelial-cidal sclerosants into the vascular spaces of the lesion, with each sclerosant possessing its own unique spectrum of advantages and disadvantages.
静脉畸形属于血管异常范畴内的低流量血管畸形,是临床上最常见的血管畸形。根据定义,静脉畸形在出生时即存在,随身体同步生长,并因与肿块效应或血液瘀滞相关的症状而出现临床症状。虽然通常可通过临床病史和检查做出诊断,但要与其他血管性和非血管性病变相鉴别,往往需要进行包括超声、CT、磁共振成像和诊断性静脉造影在内的影像学检查。所有关于影像学检查和治疗决策的决定都必须通过转诊并与多学科团队进行讨论来协调,并基于明确界定的临床指征。经皮影像引导下硬化治疗已成为静脉畸形治疗的主要方法,该方法是将多种内皮细胞杀伤性硬化剂中的任何一种引入病变的血管腔隙,每种硬化剂都有其独特的优缺点。